Skip to content

Low risk of serious kidney toxicity on tenofovir, but mild renal dysfunction cause for concern

South African Medicines Control Council says don’t use nevirapine alone for mums to be

Pilot study finds weekend breaks from HAART may be possible on NNRTIs

Could monotherapy with Kaletra become an option for HIV treatment?

IAS issue updated HIV treatment guidelines for rich countries

Abstinence debate finds more consensus than difference

Initiating HAART with any one of four 3 x 5 drug choices leads to longest survival in San Francisco

Two-year data continue to show promise for T-20

Once daily Reverset safe and effective over ten days in treatment-naïve and –experienced patients